课题基金 / 基金详情

Development of the method(s) to monitor cardiovascular function and its intracellular signal transduction

Development of the method(s) to monitor cardiovascular function and its intracellular signal transduction
监测心血管功能及其细胞内信号转导的方法的开发
批准号:
09557005
负责人:
KOBAYASHI Sei
金额:
$8.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

KOBAYASHI Sei的其他基金

相关文献

中文摘要
翻译
following results were obtained:1.第一年:我们开发了monitor cardiovascular function and its intracellular signal的方法transduction. We introduced rapidly recombinant proteins into the cytosol of vascular smooth musclestrips, using the receptor-coupled membrane permeabilization. using this new system,we identified Rho-kinase as a novel messenger for the Ca D12+ dj -independent contraction ofvascular smooth muscle. This conclusion was supported by the following results.1)混合组合catalytic domain of Rho-kinase is constitutively active and induced the Ca D12+ D1-independentcontraction of permeabilized vascular smooth muscle in the absence of cytosolic GTE. 2)Rho-kanase-induced contraction was associated with the elevation of myosin light chainphosphorylation. 3) Rho-kinase-induced contraction and increase in the myosin light chainphoshorylation were resistant to a myosin light chain kinase blocker.2. SECOND YEAR:我们投资信号transduction fro细胞membrane to cytosolic messenger (Rho-kinase). We identified several More m the cell membrane to cytosolic messengersphingolipids as a novel mediator for the Ca D12+ D1-independent contraction of vascluar smoothmuscle. In addition,we found that the sphingolipids induces Ca我们发现了D12+ D1-independent contraction in the absence ofcytosolic GTP in permeabilized vascular smooth muscle stripswhich was blocked by a Rho-kinase inhibitorsuggesting sphingolipid-induced contraction is mediated by Rho-kinase. Fluorometry of fura-2revealed that sphingolipids induced large contraction without elevation of cytosolic Ca D12+ D12concentration ([Ca D12+ d D1]i) in cerebral arteries,supporting the role of sphingolipid as a mediator for the Ca D12+ dependent contraction.3.THIRD TEAR:我们开始投资Ca D12+ D1-independent contraction of human vascular smooth muscleSphingolipid induced very small contraction obtained from patients whose cholesterol levelsare normal,but induced large contraction of the strips obtained from patients whose cholesterol level arehigh. These finding suggest that a sphingolipid/Rho-kinase pathway plays an important role in thedevelopment of abnormal vascular contraction was常quently associated with hyperlipidemia.less
英文摘要
The following results were obtained :1. FIRST YEAR : We developed the method to monitor cardiovascular function and its intracellular signal transduction. We introduced rapidly recombinant proteins into the cytosol of vascular smooth muscle strips, using the receptor-coupled membrane permeabilization. Using this new system, we identified Rho-kinase as a novel messenger for the CaィイD12+ィエD1-independent contraction of vascular smooth muscle. This conclusion was supported by the following results.1)Recombinant catalytic domain of Rho-kinase is constitutively active and induced the CaィイD12+ィエD1-independent contraction of permeabilized vascular smooth muscle in the absence of cytosolic GTE. 2) Rho-kanase-induced contraction was associated with the elevation of myosin light chain phosphorylation. 3) Rho-kinase-induced contraction and increase in the myosin light chain phoshorylation were resistant to a myosin light chain kinase blocker.2. SECOND YEAR : We investigated signal transduction fro … More m the cell membrane to cytosolic messenger (Rho-kinase). We identified several sphingolipids as a novel mediator for the CaィイD12+ィエD1-independent contraction of vascluar smooth muscle. In addition, we found that the sphingolipids induces CaィイD12+ィエD1-independent contraction in the absence of cytosolic GTP in permeabilized vascular smooth muscle strips, which was blocked by a Rho-kinase inhibitor, suggesting that sphingolipid-induced contraction is mediated by Rho-kinase. Fluorometry of fura-2 revealed that sphingolipids induced large contraction without elevation of cytosolic CaィイD12+ィエD1 concentration ([CaィイD12+ィエD1]i) in cerebral arteries, supporting the role of sphingolipid as a mediator for the CaィイD12+ィエD1-independent contraction.3. THIRD TEAR : We started to investigate the CaィイD12+ィエD1-independent contraction of human vascular smooth muscle strips. Sphingolipid induced very small contraction obtained from patients whose cholesterol levels are normal, but induced large contraction of the strips obtained from patients whose cholesterol levels are high. These finding suggest that a sphingolipid/Rho-kinase pathway plays an important role in the development of abnormal vascular contraction which was frequently associated with hyperlipidemia. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
轟-池田 奈津子: "平滑筋収縮装置のCa^<2+>感受性を増加させる新規の細胞内情報伝達機構." 麻酔. 47(5). 530-540 (1998)
Todoroki-Natsuko Ikeda:“一种新颖的细胞内信号转导机制,可增加平滑肌收缩装置的 Ca^2+ 敏感性”47(5) (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
EGUCHI, D: "Down-regulation of endothein B receptors in autogenous saphenous veins grafted into the arterial circulation."Cardiovas. Res.. 35. 360-367 (1997)
EGUCHI, D:“移植到动脉循环的自体隐静脉中内皮素 B 受体的下调。”Cardiovas。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kureishi Y: "Pho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation"J.Biol.Chem.. 272. 12257-12260 (1997)
Kureishi Y:“Pho 相关激酶通过肌球蛋白轻链磷酸化直接诱导平滑肌收缩”J.Biol.Chem.. 272. 12257-12260 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
AHMED, A: "Differential effects of CaィイD12+ィエD1 channel blockers on CaィイD12+ィエD1 transients and cell cycle progression in vascular smooth muscle cells."Eur. J. Pharmacol.. 344. 323-331 (1998)
AHMED,A:“CaiD12+D1 通道阻滞剂对血管平滑肌细胞中 CaiD12+D1 瞬态和细胞周期进展的不同影响。”Eur. J. Pharmacol.. 344. 323-331 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Elucidation of mechanism for production of causal factor of vasospasm
    • 批准号:
      23659113
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KOBAYASHI Sei
    • 依托单位:
    Identification of food component which selectively inhibits abnormal vascular contraction
    • 批准号:
      23380077
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2011
    • 负责人:
      KOBAYASHI Sei
    • 依托单位:
    Clarification of molecular mechanisms of abnormal vascular contraction by functional proteomics and a single molecular analysis of signal transduction
    • 批准号:
      20390059
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.73万
    • 财政年份:
      2008
    • 负责人:
      KOBAYASHI Sei
    • 依托单位:
    Functional roles of membrane domain and its localized component proteins in abnormal vascular contraction
    • 批准号:
      17300128
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.07万
    • 财政年份:
      2005
    • 负责人:
      KOBAYASHI Sei
    • 依托单位: